secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0000950170-23-010431
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical names new COO and Chief Clinical, Regulatory and Medical Affairs Officer
--------------------------------------------------------------------------------

- Warren Foust appointed COO effective April 24, 2023; previously Worldwide President, Johnson & Johnson Vision, Surgical.
- Magda Michna, Ph.D., appointed Chief Clinical, Regulatory and Medical Affairs Officer; previously at AcuFocus.
- Denise McEachern, Global Head of Regulatory Affairs, plans to retire after shepherding devices through approvals.
- Foust receives $550k base salary, 70% target bonus, and $2.75M equity grant with vesting schedule.
- Both new officers report to CEO Tom Frinzi; roles support growth of EVO ICL lenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017023010431/0000950170-23-010431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017023010431/staa-20230324.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-010431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer